Cargando…

Selective toxicity of TGF-alpha-PE40 to EGFR-positive cell lines: selective protection of low EGFR-expressing cell lines by EGF.

The sensitivity of human breast and lung cancer cell lines to TGF-alpha-PE40, a novel chimeric recombinant cytotoxin composed of two independent domains, (i) TGF-alpha and (ii) a 40 kDa segment of the Pseudomonas exotoxin protein, PE-40, was investigated. Toxicity varied widely, correlated with epid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kirk, J., Carmichael, J., Stratford, I. J., Harris, A. L.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1994
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1969441/ https://www.ncbi.nlm.nih.gov/pubmed/8198991

Ejemplares similares

Differential modulation of doxorubicin toxicity to multidrug and intrinsically drug resistant cell lines by anti-oestrogens and their major metabolites.
por: Kirk, J., et al.
Publicado: (1993)

EGF Potentiation of VEGF Production Is Cell Density Dependent in H292 EGFR Wild Type NSCLC Cell Line
por: Ranayhossaini, Daniel J., et al.
Publicado: (2014)

The anchorage-dependent and -independent growth of a human SCC cell line: the roles of TGF alpha/EGF and TGF beta.
por: McLeod, C., et al.
Publicado: (1990)

Regulation of the plasminogen activator system in non-small cell lung cancer cell lines by growth factors EGF, TGF-alpha and TGF-beta.
por: Heidtmann, H. H., et al.
Publicado: (1992)

Critical roles for EGFR and EGFR–HER2 clusters in EGF binding of SW620 human carcinoma cells
por: Wollman, Adam J. M., et al.
Publicado: (2022)

Genetic variations in EGF and EGFR and glioblastoma outcome
por: Sjöström, Sara, et al.
Publicado: (2010)

Expanding the Therapeutic Window of EGFR-Targeted PE24 Immunotoxin for EGFR-Overexpressing Cancers by Tailoring the EGFR Binding Affinity
por: Jun, Sei-Yong, et al.
Publicado: (2022)

Expression and Evaluation of HuscFv Antibody -PE40 Immunotoxin for Target Therapy of EGFR-Overexpressing Cancers
por: Falahatgar, Dianoush, et al.
Publicado: (2018)

CD24 associates with EGFR and supports EGF/EGFR signaling via RhoA in gastric cancer cells
por: Deng, Wenjie, et al.
Publicado: (2016)

EGFR806-CAR T cells selectively target a tumor-restricted EGFR epitope in glioblastoma
por: Ravanpay, Ali C., et al.
Publicado: (2019)

Pretreatment levels of the serum biomarkers CEA, CYFRA 21–1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients
por: Romero-Ventosa, Elena Yaiza, et al.
Publicado: (2015)

The impact of intermittent versus continuous exposure to EGFR tyrosine kinase inhibitor on selection of EGFR T790M-mutant drug-resistant clones in a lung cancer cell line carrying activating EGFR mutation
por: Lee, Youngjoo, et al.
Publicado: (2016)

PKG II Inhibits EGF/EGFR-Induced Migration of Gastric Cancer Cells
por: Jiang, Lu, et al.
Publicado: (2013)

Varying Effects of EGF, HGF and TGFβ on Formation of Invadopodia and Invasiveness of Melanoma Cell Lines of Different Origin
por: Makowiecka, A., et al.
Publicado: (2016)

Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with non-small cell lung cancer harbouring EGFR mutations
por: Holleman, Marscha S., et al.
Publicado: (2019)

RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer
por: Di Donato, Marzia, et al.
Publicado: (2023)

Protein evolution by hypermutation and selection in the B cell line DT40
por: Arakawa, Hiroshi, et al.
Publicado: (2008)

EGF Functionalized Polymer-Coated Gold Nanoparticles Promote EGF Photostability and EGFR Internalization for Photothermal Therapy
por: Silva, Catarina Oliveira, et al.
Publicado: (2016)

SMOC Binds to Pro-EGF, but Does Not Induce Erk Phosphorylation via the EGFR
por: Thomas, J. Terrig, et al.
Publicado: (2016)

Alpha6beta4 integrin crosslinking induces EGFR clustering and promotes EGF-mediated Rho activation in breast cancer
por: Gilcrease, Michael Z, et al.
Publicado: (2009)

Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines
por: Xu, Ling, et al.
Publicado: (2010)

Alterations in Genes of the EGFR Signaling Pathway and Their Relationship to EGFR Tyrosine Kinase Inhibitor Sensitivity in Lung Cancer Cell Lines
por: Gandhi, Jeet, et al.
Publicado: (2009)

Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines
por: La Monica, Silvia, et al.
Publicado: (2017)

EGFR TKI as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer
por: Nan, Xueli, et al.
Publicado: (2017)

Structural analysis of cannabinoids against EGFR-TK leads a novel target against EGFR-driven cell lines
por: Lamtha, Thomanai, et al.
Publicado: (2022)

Increased EGF receptors on human squamous carcinoma cell lines.
por: Cowley, G. P., et al.
Publicado: (1986)

The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment
por: Huang, Peixin, et al.
Publicado: (2014)

Folliculin Interacts with Rab35 to Regulate EGF-Induced EGFR Degradation
por: Zheng, Jianchao, et al.
Publicado: (2017)

HCC-derived EGFR mutants are functioning, EGF-dependent, and erlotinib-resistant
por: Sueangoen, Natthaporn, et al.
Publicado: (2020)

Significant increase in hEGF uptake is correlated with formation of EGFR dimers induced by the EGFR tyrosine kinase inhibitor gefitinib
por: He, Peng, et al.
Publicado: (2013)

Properties of resistant cells generated from lung cancer cell lines treated with EGFR inhibitors
por: Ghosh, Gargi, et al.
Publicado: (2012)

PKN1 modulates TGFβ and EGF signaling in HEC-1-A endometrial cancer cell line
por: Attarha, Sanaz, et al.
Publicado: (2014)

EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation
por: Yao, Wenfang, et al.
Publicado: (2012)

Human colon cancer cell lines secrete alpha TGF-like activity.
por: Hanauske, A. R., et al.
Publicado: (1987)

Synergistic interaction between sorafenib and gemcitabine in EGFR-TKI-sensitive and EGFR-TKI-resistant human lung cancer cell lines
por: LI, JING, et al.
Publicado: (2013)

The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma
por: Huang, Yen-Hsiang, et al.
Publicado: (2022)

EGFR Inhibitor Enhances Cisplatin Sensitivity of Oral Squamous Cell Carcinoma Cell Lines
por: Hiraishi, Yukihiro, et al.
Publicado: (2008)

Absence of constitutive EGF receptor activation in ovarian cancer cell lines.
por: Ottensmeier, C., et al.
Publicado: (1996)

Differential Expression Patterns of EGF, EGFR, and ERBB4 in Nasal Polyp Epithelium
por: Duan, Chen, et al.
Publicado: (2016)

Deficiency of GABARAP but Not Its Paralogs Causes Enhanced EGF-Induced EGFR Degradation
por: Dobner, Jochen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hqt9b7n39e9mj9muk1aqb5jt34